DaVita (MIL:1DVA) Moat Score: 7/10 (As of Jul. 12, 2026)


MIL:1DVA DaVita Inc MIL:1DVA
61 GF Score
Price €207.10
GF Value €148.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Moat Score?

DaVita MIL:1DVA 61 Moat Score is 7 as of Jul. 12, 2026. GuruFocus rates MIL:1DVA with a GF Score™ of 61/100 and a GF Value™ of €148.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 676 Healthcare Providers & Services companies, DaVita ranks better than 99.56% on this metric.

DaVita has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

DaVita has Wide Moat: DaVita Inc possesses a wide moat with durable cost advantages and significant regulatory barriers in the dialysis industry. The company has a strong brand, extensive distribution network, and high customer loyalty, ensuring a dominant market position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes DaVita might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

DaVita  (MIL:1DVA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

DaVita Moat Score Related Terms

MIL:1DVA vs THC, EHC, ENSG: Moat Score Comparison

For the Medical Care Facilities subindustry, DaVita's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DaVita Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Moat Score distribution charts can be found below:

* The bar in red indicates where DaVita's Moat Score falls into.


MIL:1DVA
61GF Score
DaVita Inc MIL:1DVA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
DaVita (MIL:1DVA) has a Moat Score of 7 as of Jul. 12, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, DaVita ranks #3 out of 676 companies in the Healthcare Providers & Services industry, placing it in the top 0.40000000000001%.
Is DaVita's Moat Score too high?
DaVita's current Moat Score is 7. Based on the distribution chart, DaVita ranks #3 out of 676 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Moat Score compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #3 out of 676 companies for Moat Score. This places DaVita in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. DaVita's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MIL:1DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is €148.57, compared to a current price of €207.10 — trading 39.4% above its estimated fair value. The current Moat Score is 7. DaVita's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For DaVita (MIL:1DVA), the current Moat Score is 7 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MIL:1DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €207.10 is trading 39.4% above its estimated GF Value™ of €148.57. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MIL:1DVA:

  • Moat Score: 7
  • GF Value™: €148.57 vs. price of €207.10 (39.4% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the MIL:1DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
61GF Score

Get the complete analysis for MIL:1DVA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€207.10
Price
€148.57
GF Value